Last reviewed · How we verify
NCT06175728: S-PRESS
Feasbility and Efficacy of S-Press Leg Strengthening Device
NA trial testing S-Press in Deconditioning in 9 participants. Completed in 4 September 2023.
31 January 2023
Quick facts
| Lead sponsor | Sheffield Hallam University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 9 |
| Start date | 1 April 2021 |
| Primary completion | 31 January 2023 |
| Estimated completion | 4 September 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- S-Press
Conditions studied
- Deconditioning — all drugs for Deconditioning →
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Sheffield Hallam University
Who can join
18 and older, any sex, with Deconditioning or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study will examine the use and effectiveness of a novel strength training device - The S-Press within an NHS environment. The S-Press is a portable exercise device that can be used seated or lying down and specifically targets the knee extensors and flexors. The knee extensors are particularly important in the performance of activities of daily living such as rising from a chair, walking up and down stairs and walking. Resistance training is the most effective strategy to help to reduce muscle wasting in response to ageing or chronic disuse; however as current in-patient settings likely fail to produce an overload stimulus to the muscle for hypertrophy and strength gains, there is a need to develop new interventions and equipment to help deliver this. The S-Press is designed by a Physiotherapist with the goal of increasing muscle strength and improving physical function in patients who may be confined to their bed or chair or unable to join in with standard physiotherapy treatments. This mixed methods study will examine the efficacy of the S-Press to improve muscle size using B-Mode Ultrasound and physical function, using sit to stand x5 with use over 6 weeks, alongside the qualitative experience of the use of the S-Press through a one to one semi structured interview.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feasibility, usability, acceptability and Efficacy of a novel leg strengthening device (S-Press) for strengthening leg muscles and improving physical impairment during hospital admission
Maden-Wilkinson T, Griffiths C, Lakkappa B, Walker K, et al · · 2024 · cited 1× · DOI 10.1101/2024.01.15.24301211
Verify or expand the search:
- PubMed search for NCT06175728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deconditioning
Currently open trials in the same condition.
- NCT06932224 — This Study Aims to Measure the Effect of Acute Hospitalisation on the Physical and Cognitive Functioning of Older Orthop · recruiting
Other Sheffield Hallam University trials
Trials by the same sponsor.
- NCT07373483 — Observing 3-5 Year Old Children's Use of Interactive Electronic Devices (IED) in the Family Home to Understand the Conte · recruiting
- NCT07585474 — Gut Microbiome Response to Long-Haul Travel in Elite Football Players · NA · enrolling by invitation
- NCT06810570 — The Effect of Mobile Devices on the Development and Health of Young Children · recruiting
- NCT06094517 — What Are Persistent Lower Back Pain Patients' Views of Sleep Health Within an Outpatient Musculoskeletal Physiotherapy S · unknown
- NCT06101875 — Health Coaching for Patients Waiting for Hip or Knee Replacements · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06175728 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sheffield Hallam University
- Last refreshed: 19 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06175728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing